THE CHILD WITH HEMORRHAGIC SYNDROME
About the Author
Ю. ЛашковаRussian Federation
References
1. Nurden A. T. Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006 Apr 6; 1: 10.
2. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997 May 24; 349 (9064): 1531–6.
3. Laffan M. A., Lester W., O’Donnell J. S., Will A., Tait R. C., Goodeve A., Millar C. M., Keeling D. M. The diagnosis and manage ment of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol. 2014 Nov; 167 (4): 453–65.
4. Franchini M., Frattini F., Crestani S., Bonfanti C. Haemophilia B: current pharmacotherapy and future directions. Expert Opin Pharmacother. 2012 Oct; 13 (14): 2053–63.
5. Van Winckel M., De Bruyne R., van De Velde S., van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr. 2009 Feb; 168 (2): 127–34.
6. Shearer M. J., Fu X., Booth S. L. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr. 2012 Mar 1; 3 (2): 182–95.
7. Shearer M. J. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev. 2009 Mar; 23 (2): 49–59.
8. Puckett R. M., Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev. 2000; 4: CD002776
Review
For citations:
THE CHILD WITH HEMORRHAGIC SYNDROME. Pediatric pharmacology. 2015;12(2):201-203.